Jiangsu Sihuan Bioengineering Co., Ltd (SHE:000518)

SHE:000518 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	85.98	8.01	18.93	28.18	38.11	54.59
Trading Asset Securities	0.15	0.17	0.14	0.16	0.23	-
Cash & Short-Term Investments	86.13	8.18	19.06	28.34	38.34	54.59
Cash Growth	491.73%	-57.07%	-32.74%	-26.07%	-29.77%	2.85%
Accounts Receivable	81.61	72.95	75.32	110.11	139.13	150.21
Other Receivables	0.99	0.98	1.27	9.37	3.16	6.9
Receivables	82.6	73.93	76.58	119.48	142.29	157.11
Inventory	222.26	359.88	408.53	408.76	430.67	449.14
Prepaid Expenses	-	0.03	0.08	3.4	3.4	2.3
Other Current Assets	5.85	4.59	5.12	4.84	5.75	5.79
Total Current Assets	396.84	446.61	509.38	564.82	620.44	668.93
Property, Plant & Equipment	69.63	75.06	84.09	85.06	92.04	84.49
Long-Term Investments	-	0.08	-	0.54	0.74	1.33
Other Intangible Assets	10.29	11.43	30.01	31.07	23.31	29.03
Long-Term Deferred Tax Assets	5.43	4.84	4.9	5.21	4.5	5.31
Long-Term Deferred Charges	-	-	-	15.58	17.98	15
Other Long-Term Assets	26.96	29.38	32.59	35.8	40.31	19.62
Total Assets	509.14	567.4	660.98	738.08	799.31	823.71
Accounts Payable	53.68	60.57	49.89	52.7	60.77	57.63
Accrued Expenses	0.34	9.6	10.29	12.35	7.98	8.1
Short-Term Debt	-	9.5	16.02	16	16.01	16.02
Current Portion of Leases	4.99	5.63	5.41	4.38	4.29	-
Current Income Taxes Payable	5.3	1.94	1.94	1.94	1.94	6.05
Current Unearned Revenue	9.34	32.35	16.75	18.62	18.52	18.02
Other Current Liabilities	15.57	14.16	17.85	10.22	11.42	31.85
Total Current Liabilities	89.22	133.75	118.15	116.22	120.93	137.66
Long-Term Leases	21.47	21.14	26.47	28.37	30.8	-
Long-Term Unearned Revenue	-	-	-	-	0.8	1
Other Long-Term Liabilities	12.98	13.54	3.57	-	-	-
Total Liabilities	123.67	168.43	148.19	144.58	152.54	138.66
Common Stock	1,030	1,030	1,030	1,030	1,030	1,030
Additional Paid-In Capital	35.57	35.57	35.57	35.57	35.57	35.57
Retained Earnings	-706.73	-694.03	-584.04	-508.77	-459.97	-425.18
Comprehensive Income & Other	0.61	0.61	0.61	0.88	0.88	0.88
Total Common Equity	359.02	371.71	481.71	557.24	606.03	640.82
Minority Interest	26.46	27.26	31.07	36.25	40.74	44.22
Shareholders' Equity	385.48	398.97	512.78	593.5	646.78	685.05
Total Liabilities & Equity	509.14	567.4	660.98	738.08	799.31	823.71
Total Debt	26.46	36.27	47.9	48.75	51.1	16.02
Net Cash (Debt)	59.67	-28.09	-28.84	-20.41	-12.77	38.58
Net Cash Growth	-	-	-	-	-	4.08%
Net Cash Per Share	0.06	-0.03	-0.03	-0.02	-0.01	0.04
Filing Date Shares Outstanding	1,030	1,030	1,030	1,030	1,030	1,030
Total Common Shares Outstanding	1,030	1,030	1,030	1,030	1,030	1,030
Working Capital	307.62	312.86	391.23	448.6	499.51	531.27
Book Value Per Share	0.35	0.36	0.47	0.54	0.59	0.62
Tangible Book Value	348.73	360.28	451.7	526.18	582.72	611.79
Tangible Book Value Per Share	0.34	0.35	0.44	0.51	0.57	0.59
Buildings	-	60.75	57.74	57.74	57.74	68.57
Machinery	-	83.26	81.89	78.07	74.95	78.4
Construction In Progress	-	-	3.94	2.13	-	12.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.